title: [Treatment of primary osteoporosis in men].
abstract: Primary osteoporosis in men occurs less frequently and thus tends to be less noticed than that in women. However, once a femoral neck fracture occurs in men, patients are more likely to be disabled than women. Thus, implementing treatments of osteoporosis before the occurrence of femoral neck fractures is important in terms of men's quality of life. Several studies have shown that bisphosphonate is a mainstay of the treatment of the disorder, by increasing bone mineral density and reducing the risk of vertebral fractures.
authors.affiliation: Shimane University Faculty of Medicine, Department of Medicine, Division of Endocrinology/Metabolism and Hematology/Oncology.
authors.forename: Toru
authors.initials: T
authors.lastname: Yamaguchi
authors.forename: Toshitsugu
authors.initials: T
authors.lastname: Sugimoto
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D002116:Calcitonin / Q000008:administration & dosage; D004164:Diphosphonates / Q000008:administration & dosage*; D005265:Femoral Neck Fractures / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000008:administration & dosage; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D010281:Parathyroid Hormone; D002116:Calcitonin